Grace Therapeutics (GRCE) Cash & Equivalents (2017 - 2026)
Grace Therapeutics (GRCE) recorded Cash & Equivalents of $13.76 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 617.2% from $1.92 million a year earlier but down 19.0% from the prior quarter.
Powered by 
Analysis
Grace Therapeutics (GRCE) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Cash & Equivalents of $16.98 million, down 23.3% from FY2025.
- Annual Cash & Equivalents has declined for five straight fiscal years, with a five-year compound annual growth rate of -19.7% (FY2021 to FY2026).
- Across earlier fiscal years, Cash & Equivalents came in at $22.13 million in FY2025 (-3.8%), $23.01 million in FY2024 (-17.5%), $27.88 million in FY2023 (-8.1%) and $30.34 million in FY2022 (-40.4%).
- Quarterly Cash & Equivalents has ranged from $1.92 million in fiscal Q1 2026 to $38.38 million in fiscal Q1 2023 over the past five years.
- On a year-over-year basis, Cash & Equivalents rose in three of the last eight quarters, with growth averaging 62.0%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 617.2% in fiscal Q1 2027, against a decline of 90.1% in fiscal Q1 2026 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $16.98 million (Q4 2026), $18.67 million (Q3 2026) and $16.86 million (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Grace Therapeutics | 32.47 Mn | -33.80 Mn | - | 13.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.76 Mn |
| Mar 31, 2026 | 16.98 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 16.86 Mn |
| Jun 30, 2025 | 1.92 Mn |
| Mar 31, 2025 | 22.13 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Sep 30, 2024 | 15.16 Mn |
| Jun 30, 2024 | 19.39 Mn |
| Mar 31, 2024 | 23.01 Mn |
| Dec 31, 2023 | 18.55 Mn |
| Sep 30, 2023 | 26.99 Mn |
| Jun 30, 2023 | 21.63 Mn |
| Mar 31, 2023 | 27.88 Mn |
| Dec 31, 2022 | 26.24 Mn |
| Sep 30, 2022 | 34.93 Mn |
| Jun 30, 2022 | 38.38 Mn |
| Mar 31, 2022 | 30.34 Mn |
| Dec 31, 2021 | 33.01 Mn |
| Sep 30, 2021 | 36.93 Mn |
API Access
Grace Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRCE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();